Printable Version

Churman, Mark Herman Carl

CPSO#: 70673

MEMBER STATUS

Active Member as of 08 Jul 1996

CURRENT OR PAST CPSO REGISTRATION CLASS

Independent Practice as of 04 Apr 2024

Summary

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui. Vivamus suscipit tortor eget felis porttitor volutpat. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Curabitur aliquet quam id dui posuere blandit. Vivamus suscipit tortor eget felis porttitor volutpat. Curabitur arcu erat, accumsan id imperdiet et, porttitor at sem. Vestibulum ac diam sit amet quam vehicula elementum sed sit amet dui. Donec sollicitudin molestie malesuada. Pellentesque in ipsum id orci porta dapibus.

Former Name: No Former Name

Gender: Male

Languages Spoken: English

Education: McMaster University, 1994

Practice Information

Primary Location of Practice

14 Armstrong Street North
New Liskeard ON P0J 1P0
Phone: 705-679-4078 Electoral District: 08

Professional Corporation Information

Corporation Name: Dr. Mark Churman Medicine Professional Corporation
Certificate of Authorization Status: Inactive: May 19 2021

Corporation Name: Dr. Mark Churman Medicine Professional Corporation
Certificate of Authorization Status: Issued Date: May 25 2021

Shareholders:
Dr. M. Churman ( CPSO# 70673 )

Business Address:
722114 Apaloose Dr
New Liskeard ON P0J 1P0
Phone Number: 7056481439

Hospital Privileges

Hospital	Location
Temiskaming Hospital	New Liskeard

Specialties

Specialty	Issued On	Type
Family Medicine	Effective:05 Jun 1996	CFPC Specialist

Terms and Conditions

(1) Dr. MARK HERMAN CARL CHURMAN may practise only in the areas of medicine in which Dr. CHURMAN is educated and experienced.

Registration History

Action	Issue Date
First certificate of registration issued: Independent Practice Certificate	Effective: 08 Jul 1996
Terms and conditions amended by member	Effective: 31 Jan 2024
Transfer of class of registration to: Independent Practice Certificate	Effective: 04 Apr 2024